University of Pittsburgh, Hillman Cancer Center — Pittsburgh, Pennsylvania

University of Pittsburgh, Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Pittsburgh, Hillman Cancer Center has participated in 3 clinical trials.

Therapeutic areas: Advanced Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Soft Tissue Sarcoma.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA, Abramson Cancer Center at Penn Medicine, University of Pittsburgh.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburgh, Hillman Cancer Center?

University of Pittsburgh, Hillman Cancer Center has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburgh, Hillman Cancer Center conducted?

University of Pittsburgh, Hillman Cancer Center has 3 clinical trials on record. Their work covers Advanced Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Soft Tissue Sarcoma.

Is University of Pittsburgh, Hillman Cancer Center accredited by Crixeo Health?

University of Pittsburgh, Hillman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pittsburgh, Hillman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.